Literature DB >> 8267592

ADP-ribosylation of the intermediate filament protein desmin and inhibition of desmin assembly in vitro by muscle ADP-ribosyltransferase.

H Y Huang1, D J Graves, R M Robson, T W Huiatt.   

Abstract

Arginine-specific mono(ADP-ribosyl)transferase purified from rabbit skeletal muscle catalyzes stoichiometric ADP-ribosylation of the intermediate filament protein, desmin. In contrast, cholera toxin catalyzes a much lower level of ADP-ribosylation of desmin. Modification results in potent inhibition of desmin's ability to assemble into filaments. Phosphorylation of desmin by the catalytic subunit of cAMP dependent protein kinase is also inhibited by ADP-ribosylation. ADP-ribosylation site(s) are located within the N-terminal head domain of desmin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8267592     DOI: 10.1006/bbrc.1993.2517

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Molecular and biological characterization of Streptococcal SpyA-mediated ADP-ribosylation of intermediate filament protein vimentin.

Authors:  Laura M Icenogle; Shawna M Hengel; Lisette H Coye; Amber Streifel; Carleen M Collins; David R Goodlett; Steve L Moseley
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

Review 2.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

Review 3.  Posttranslational modifications of desmin and their implication in biological processes and pathologies.

Authors:  Daniel L Winter; Denise Paulin; Mathias Mericskay; Zhenlin Li
Journal:  Histochem Cell Biol       Date:  2013-10-04       Impact factor: 4.304

4.  Side chain specificity of ADP-ribosylation by a sirtuin.

Authors:  Kamau Fahie; Po Hu; Stephen Swatkoski; Robert J Cotter; Yingkai Zhang; Cynthia Wolberger
Journal:  FEBS J       Date:  2009-11-06       Impact factor: 5.542

Review 5.  New PARP targets for cancer therapy.

Authors:  Sejal Vyas; Paul Chang
Journal:  Nat Rev Cancer       Date:  2014-06-05       Impact factor: 60.716

Review 6.  ADP-ribosylation of arginine.

Authors:  Sabrina Laing; Mandy Unger; Friedrich Koch-Nolte; Friedrich Haag
Journal:  Amino Acids       Date:  2010-07-21       Impact factor: 3.520

7.  Endogenous mono-ADP-ribosylation of the free Gbetagamma prevents stimulation of phosphoinositide 3-kinase-gamma and phospholipase C-beta2 and is activated by G-protein-coupled receptors.

Authors:  Rosita Lupi; Nadia Dani; Alexander Dietrich; Adriano Marchegiani; Sabrina Turacchio; Christopher P Berrie; Joel Moss; Peter Gierschik; Daniela Corda; Maria Di Girolamo
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

Review 8.  Functional aspects of protein mono-ADP-ribosylation.

Authors:  Daniela Corda; Maria Di Girolamo
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.